Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 1/20 | 0.47 |
| ▸ | GPR52 | Q9Y2T5 | 2/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.38 |
| ▸ | PRKCI | P41743 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4444152 | 0.86 | PTGS2 (0.40) | AGXTGPR52GPR84PTGS2GGPS1 | |
| SCHEMBL27522397 | 0.84 | PTGS2 (0.39) | AGXTGPR52GPR84PTGS2MAOB | |
| SCHEMBL3153258 | 0.82 | ESR1 (0.44) | GPR52HRH3BACE1FFAR4TAAR1 | |
| SCHEMBL10639413 | 0.82 | FFAR1 (0.48) | AGXTGPR52GPR84FFAR1TAAR1 | |
| SCHEMBL49747 | 0.81 | ALDH1A1 (0.48) | GPR52MAOAMAOBTAAR1 | |
| SCHEMBL418611 | 0.81 | GPR52 (0.50) | AGXTGPR52GPR84GGPS1AOC3 | |
| SCHEMBL19759484 | 0.80 | MAOA (0.35) | GPR52GPR84MAOAMAOB | |
| SCHEMBL5629303 | 0.80 | PTGS2 (0.60) | AGXTGPR84PTGS2GGPS1AOC3 | |
| SCHEMBL16681696 | 0.79 | ALDH1A1 (0.46) | GPR52MAOAMAOBTAAR1 | |
| Ammonia Solution, Strong SCHEMBL11487919 | 0.79 | ALDH1A1 (0.46) | GPR52MAOAMAOBTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109385021-A | A kind of compositions of thermosetting resin and prepreg and metal-clad laminate using its production | 广东生益科技股份有限公司 | 2019-02-26 | — | — | CN | disclosed |
| CN-109385020-A | A kind of compositions of thermosetting resin and prepreg and metal-clad laminate using its production | 广东生益科技股份有限公司 | 2019-02-26 | — | — | CN | disclosed |
| CN-109385018-A | A kind of compositions of thermosetting resin and prepreg and metal-clad laminate using its production | 广东生益科技股份有限公司 | 2019-02-26 | — | — | CN | disclosed |
| EP-2984055-B1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA INC (US) | 2018-10-17 | — | — | EP | disclosed |
| US-9758445-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-9663459-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. | 2016-06-30 | — | — | US | disclosed |
| US-20160145204-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. | 2016-05-26 | — | — | US | disclosed |
| WO-2015126462-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. (US) | 2015-08-27 | — | — | WO | disclosed |
| CN-1914239-B | Curable resin composition | NIPPON STEEL CHEMICAL CO | 2010-05-05 | — | — | CN | disclosed |
| CN-1914239-A | Curable resin composition | NIPPON STEEL CHEMICAL CO (JP) | 2007-02-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | SMURF2, EPHX2, SMURF1 | AGXT 743/4885GPR52 2922/4885GPR84 3095/4885 |
| US-20160145204-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | SMURF2, SMURF1, ABCB4 | AGXT 1557/4885GPR52 3419/4885GPR84 2964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.